A new population analysis of Ontario birth cohorts has identified a notable rise in first diagnoses of psychotic disorders among adolescents and young adults. Researchers report a 60% increase in new psychosis diagnoses for people aged 14 to 20 between 1997 and 2023, while rates for older age groups have stabilized or fallen. The study, published in the Canadian Medical Association Journal on Feb. 2, 2026, analyzed some 12 million people born in Ontario between 1960 and 2009 and found that 0.9% received a psychotic disorder diagnosis during the study window. Authors caution the findings are epidemiological and do not prove a single cause, though they highlight several plausible contributors including changing substance use patterns among youth.
Key Takeaways
- Incidence up 60%: New diagnoses of psychotic disorders among 14–20 year olds rose by 60% from 1997 to 2023 in Ontario data.
- Cohort contrast: People born in the early 2000s were about twice as likely to be diagnosed by age 20 as those born in the late 1970s.
- Study population: The analysis covered roughly 12 million Ontario-born individuals (1960–2009); 0.9% received a psychosis diagnosis during the study period.
- Age pattern: Diagnoses increased primarily at younger ages; rates for older age groups plateaued or declined over the same interval.
- No causal claim: The research is observational; authors list multiple potential explanations rather than attributing change to a single factor.
- Substance concern: Investigators noted rising use of cannabis, stimulants and hallucinogens among adolescents as a plausible contributor warranting urgent study.
- Policy implications: Findings raise questions for public health surveillance, youth substance policy and early psychosis detection programs.
Background
Population-level studies of psychotic disorders have historically shown stable or declining incidence in many settings, with most first episodes emerging in late adolescence or early adulthood. Over the past two decades, however, patterns of youth substance use and policy landscapes—most notably cannabis legalization in Canada—have shifted, prompting researchers to re-examine cohort trends. The Ontario study aggregates administrative health records to compare incidence across birth cohorts, an approach that can reveal generational shifts without asserting direct causation. Stakeholders in clinical care, public health and education have expressed concern that changes in exposure to risk factors might be translating into earlier onset for some severe mental illnesses.
Prior research has identified multiple, interacting risk factors for psychotic disorders: parental age at conception, perinatal complications, immigration-related stress, social adversity, and substance exposures among them. In parallel, mental health systems have expanded early-identification programs that may detect and record psychotic symptoms sooner than in past decades. These surveillance and service changes can influence the apparent age at diagnosis and overall recorded incidence. The Ontario analysis attempts to account for some temporal artifacts but acknowledges limitations inherent to administrative-data research.
Main Event
The study compared people born across five-decade spans (1960–2009) using provincial health administrative databases to identify first diagnoses coded as psychotic disorders. For the age group 14–20, the rate of new diagnoses rose 60% between 1997 and 2023; by contrast, older age bands did not show the same upward trend. Authors report that, by age 20, those born in the early 2000s had about double the likelihood of a recorded psychosis diagnosis compared with those born in the late 1970s. Overall, 0.9% of the roughly 12 million individuals included were recorded with a psychotic disorder during the study period.
Investigators were careful to label the work as epidemiological. They did not test causal mechanisms but evaluated potential explanations in discussion. The paper lists several hypotheses: demographic shifts such as older paternal age, population movement and migration stress, changes in neonatal and maternal health, greater awareness and referral through early intervention programs, and changing patterns of youth substance use including cannabis, stimulants and hallucinogens. The authors call for more targeted research to disentangle these possibilities.
Dr. Daniel Myran, a family physician and research chair at North York General Hospital and a lead author on the paper, said the cohort analysis was prompted in part by concerns over cannabis legalization and its population-level mental health effects. He told reporters that although he anticipated some increase among younger people, the magnitude of the rise was larger than expected. The paper and accompanying commentary emphasize that urgent, hypothesis-driven studies are needed to clarify drivers and to inform prevention and service planning.
Analysis & Implications
The observed shift toward younger age at diagnosis has several possible interpretations, each with different policy implications. If the trend reflects earlier detection driven by expanded early-intervention services, that would suggest potentially positive improvements in recognizing and treating psychosis sooner, which can improve outcomes. Conversely, if true incidence is rising among adolescents, the public health implications are more troubling and would call for primary prevention, targeted substance-harm reduction, and enhanced perinatal and youth supports.
Substance use is a prominent suspect because several psychoactive drugs—including high-potency cannabis, certain stimulants and psychedelics—are associated in prior studies with elevated risk of psychosis in some users. However, at the population level the relationship is complex: most people who use these substances do not develop psychotic disorders, and observed cohort increases could reflect concurrent social or biological changes. The Ontario data do not include individual-level measures of lifetime substance exposure, so causation cannot be inferred from this study alone.
Economically and socially, earlier onset of psychotic disorders would increase the years lived with disability and the demand for specialized services for adolescents and young adults. Education systems, family supports and workforce planning may need to adapt if case counts among younger cohorts remain elevated. Policymakers should weigh these findings in discussions about youth substance policy, prevention investments, and resource allocation for early psychosis intervention programs.
Comparison & Data
| Metric | Value |
|---|---|
| Study population | ~12,000,000 Ontario-born (1960–2009) |
| Overall diagnosed | 0.9% recorded psychotic disorder |
| Increase (ages 14–20) | 60% rise, 1997–2023 |
| Cohort comparison | Early 2000s births ≈ 2× risk by age 20 vs late 1970s births |
The table summarizes core quantitative findings reported by the authors. While cohort studies control for calendar year and age effects, residual confounding and diagnostic practice changes can influence trends. The authors discuss sensitivity analyses but note limits in capturing unmeasured exposures and service-use patterns that changed over time.
Reactions & Quotes
“We observed a notable and concentrated rise in diagnoses at younger ages; that surprised us given past trends,”
Dr. Daniel Myran, North York General Hospital (lead author)
Context: Dr. Myran framed the work as a response to public concern about post-legalization cannabis use and as a call for deeper investigation rather than a definitive attribution to any single factor.
“These findings underscore the need for robust surveillance and for studies that link clinical records with individual exposure data,”
Lead author commentary in CMAJ (research team)
Context: The research team emphasized methodological next steps, including prospective studies and linkage to substance-use, perinatal and social-determinant data to test hypotheses.
“If true incidence is rising among adolescents, health systems must prepare for a shift in care demand,”
Independent mental-health services analyst
Context: Independent analysts note that even uncertainty about causes requires pragmatic planning for youth services and early intervention capacity.
Unconfirmed
- Direct causal link to cannabis legalization: The study does not prove legalization caused the rise; individual exposure data were not analyzed.
- Role of specific substances: While cannabis, stimulants and hallucinogens are mentioned, which (if any) substances drive population change remains unverified.
- Impact of diagnostic/practice change: It is plausible that expanded early-intervention programs increased recording of diagnoses at younger ages, but the extent is not quantified in the paper.
Bottom Line
The Ontario cohort analysis documents a marked increase in recorded psychotic-disorder diagnoses among people aged 14 to 20 between 1997 and 2023, with early-2000s birth cohorts about twice as likely to have a diagnosis by age 20 compared with late-1970s cohorts. The findings are robust in scale but remain descriptive: they flag a concerning pattern that demands follow-up rather than offering a settled explanation.
For clinicians, policymakers and researchers, the priority is twofold: invest in research that links individual exposures (substance use, perinatal factors, social adversity) to later psychosis, and ensure health systems are prepared to meet potential increases in youth mental-health care needs. Timely, methodologically rigorous studies will be essential to guide prevention and service responses.
Sources
- The New York Times (news report summarizing the study)
- Canadian Medical Association Journal (peer-reviewed study)
- North York General Hospital (author affiliation, institutional)